ARCHIVES

OMB Revisions Would Kill 16 Center core Grants, Ban New Ones, Slash Noncompeting Funds 10 Percent

This article is from The Cancer Letter archive.

Vol. 09 No. 15 | April 15, 1983

Download PDF Visit The Full Archive

Related Articles

Two-Point Rise In PSA Signals High-Risk Prostate Cancer

August 26, 2005

Zometa Better Than Placebo In Treatment Of Bone Mets

August 31, 2001

ACS Supports NCI’s Bypass Budget In Resolution

March 20, 1992

Specialists List 15 Criteria For Choosing Health Insurance.

January 14, 2000

Lenalidomide, An Altered Thalidomide, Shows Promise

November 24, 2006

ASCO Places Ad To Urge Increase In Research Funding.

June 13, 2008